GlassScriptPhysician profile
Jacob L Freeman
NPI 1649412669
$35,109.39
in general payments reported to CMS, 2019-2025
23 companies · $1,405 in 2025
The $1,405 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $17K · 2021: $561 · 2022: $664 · 2023: $714 · 2024: $1,069 · 2025: $1,405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,180 · Travel and Lodging: $7.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,180.20 |
| Travel and Lodging | $7.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $28,403.69 | 2019-2020 | |
| Medtronic, INC. | $1,864.93 | 2021-2025 | Mazor X System, Catalyft Pl Expandable Interbody System, Stealthstation S8 Platform |
| Kairos Surgical INC | $1,086.00 | 2019 | |
| Nevro Corp. | $810.56 | 2019-2023 | Senza |
| Boston Scientific Corporation | $687.39 | 2020-2025 | Wavewriter Alpha Prime 16, Innova Vascular, Eluvia |
| Orthofix Medical, INC. | $456.80 | 2019-2025 | Explorer To, Northstar |
| Surgical Theater. INC. | $453.88 | 2023-2025 | |
| Si-Bone, INC. | $267.96 | 2020-2023 | |
| Xenix Medical LLC | $220.74 | 2025 | |
| Stryker Corporation | $174.41 | 2019-2022 | |
| Relievant Medsystems, INC. | $106.74 | 2023 | Intracept |
| Integra Lifesciences Corporation | $87.97 | 2019-2022 | |
| 7d Surgical INC. | $87.89 | 2020 | |
| Zimmer Biomet Holdings, INC. | $87.63 | 2019-2021 | |
| Depuy Synthes Sales INC. | $73.56 | 2023-2024 | Trumatch, Synthecel, Conduit |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Providence Medical Technology, INC. | $70.55 | 2019-2025 | |
| Globus Medical, INC. | $44.64 | 2023 | Rise-L . Rise-L A/L |
| Arteriocyte Medical Systems, INC. | $29.02 | 2024 | Magellan |
| Abbott Laboratories | $22.73 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $21.65 | 2021 | |
| Ethicon US, LLC | $18.74 | 2020 | |
| Azurity Pharmaceuticals, INC. | $17.50 | 2023 | Gliadel |
| Smith+Nephew, INC. | $14.41 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Freeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.